Authors
Latest:
Predicting Clinical Needs and Potential for Genetic Therapies in ALS: Jennifer Morganroth, MD, MBAAt the 2023 MDA’s Clinical and Scientific conference, the neurology resident at Penn Medicine talked about the challenges of delivering intrathecal therapies and the importance of planning clinical resources for patients with ALS. [WATCH TIME: 3 minutes]
Latest:
Ensuring Safe Pregnancy and Postpartum Care for Patients With Multiple Sclerosis: Anna Shah, MDThe assistant professor of neurology at the University of Colorado School of Medicine talked about the importance of addressing family planning with patients with multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Assessing Treatment Decisions for Myasthenia Gravis: George Small, MDThe adult neurologist at Allegheny Health Network provided insight on the steps taken to ensure a patient with myasthenia gravis is on an effective and safe therapy. [WATCH TIME: 7 minutes]
Latest:
A Melting Pot of Strategies and Collaboration at the 2025 MDA Conference: Sharon Hesterlee, PhDThe chief research officer of the Muscular Dystrophy Association talked about what is to be expected at the 2025 MDA Conference, held March 16-19, in Dallas, Texas. [WATCH TIME: 5 minutes]
Latest:
Adding to the Literature of KIF5A in ALS Pathogensis: Devesh Pant, PhDThe instructor in the department of cell biology at Emory University provided context on a presentation at MDA 2024 regarding mutations in Kif5a in familial forms of amyotrophic lateral sclerosis. [WATCH TIME: 4 minutes]
Latest:
Dual-Orexin Receptor Antagonists for Treatment of InsomniaIn an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.
Latest:
Helping Your Patients Avoid the Migraine Trigger TrapForget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.
Latest:
Novel Approaches to Challenges in Treating Migraine: Carrie Dougherty, MD, FAHSThe program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the potential of INP104 to improve migraine patient care.
Latest:
ChatGPT: A Promising Tool to Combat Social Isolation and Loneliness in Older Adults With Mild Cognitive ImpairmentRecent advances in artificial intelligence—particularly conversational AI tools such as ChatGPT—suggest promising potential in addressing the issues of loneliness and social isolation in these patient populations.
Latest:
Future Directions for the Management of MigraineBradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.
Latest:
Chariot MS Study of Off-Label Cladribine in Advanced MS: Kimberly Allen-PhilbeyThe PhD candidate at the Barts MS Center in London discussed the upcoming Chariot MS study as well as further research she would like to conduct in personalized cladribine dosing.
Latest:
Kristina Simonyan, MD, PhD, DrMed: Using Machine Learning to Diagnose DystoniaThe director of Laryngology Research at Mass Eye and Ear spoke to the use of machine learning programs to aid physicians in the diagnosis of dystonia.
Latest:
Important Changes Are Coming to Medicare in 2025: What You Need to Know to Help Your PatientsNicole M. Boschi, PhD, the director of regulatory affairs at the National MS Society, talked about the impact of the upcoming Medicare Part D and Medicare Advantage changes for the multiple sclerosis community.
Latest:
Gaps in Care in Myasthenia Gravis and Take-Home PointsEricka Wong, MD, comments on gaps in care in myasthenia gravis and provides take-home messages for physicians treating patients with this condition.
Latest:
Incorporating Digital Cognitive Assessments in Real-World Practice: Nicole Fowler, PhDThe director of research for internal medicine and geriatrics at Indiana University School of Medicine discussed the advantages digital assessments bring to clinics, and what role they will play in the coming years. [WATCH TIME: 3 minutes]
Latest:
The Future of Digital Neuropathology and the Role of AI: John F. Crary, MD, PhD; Gerardo Fernandez, MDThe neuropathologist at Mount Sinai and chief science officer of Precise Dx pairing spoke to the role of artificial intelligence in the diagnosis of diseases from peripheral tissue biopsies and its ability to improve neuropathology. [WATCH TIME: 8 minutes]
Latest:
Advances in Multifaceted Drug Approaches for Dementia in Movement Disorders: Charbel Moussa, MBBS, PhDThe associate professor of neurology at Georgetown University Medical Center talked about innovative treatments for dementia in movement disorders that target multiple mechanisms to effectively modify the disease. [WATCH TIME: 7 minutes]
Latest:
Greatest Unmet Needs in Sleep Disorder Care: Asim Roy, MDThe medical director of the Ohio State Sleep Medicine Institute provided insight on areas within sleep disorder care that need improvement, including the diagnostic process.
Latest:
EEG TalkEEG Talk is a series dedicated to teaching electroencephalogram (EEG) reading skills in neurology in a way that is both digestible and fun. New episodes featuring special guests in the field are posted regularly on Mondays.
Latest:
Patient Reported Outcomes and Clinical Disability Outcomes in MS demonstrate the same rates of worsening when performed in neurology clinic, patient registry, and a clinical trialJason Freeman, MD, MBA, and Hunter Davis, PharmD, discuss the poster “Patient Reported Outcomes and Clinical Disability Outcomes in MS demonstrate the same rates of worsening when performed in neurology clinic, patient registry, and a clinical trial” presented at AAN 2023. Sponsored By Novartis.
Latest:
The Future of Innovative Neurorestoration Approaches: Joe Kardine, MS, OTR, CBISThe clinical program manager at the Jefferson Center for Neurorestoration provided commentary on the state of neurorestoration and constant transformation of the space. [WATCH TIME: 3 minutes]
Latest:
Strategies for Managing Changes in Cognitive Function in Multiple Sclerosis: Meghan Beier, PhD, MAIn recognition of World MS Day, the health and rehabilitation psychologist at the Rowan Center for Behavioral Medicine discussed types of interventions for managing cognitive changes in patients with multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
The State of Biomarkers in Multiple SclerosisAs the field of MS care turns its sights on addressing progressive disease, the need for more biomarkers of disease activity and therapeutic target engagement is perhaps greater than ever.
Latest:
Need for Research on Social Determinants of Health for Stroke Outcomes: Ralph Sacco, MD, MS, FAAN, FAHAThe chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine detailed the reasons behind the lack of research on social determinants of health on stroke outcomes.
Latest:
Future Directions and Takeaways Regarding Anti-CD20 Therapies in MSAhmed Obeidat, MD, PhD, Riley Bove, MD, Stephen Krieger, MD, and Erin Longbrake, MD, PhD, share perspectives on the future of MS care, the importance of vigilance in lab testing, and why patients may need reassurance about the potential for disease control with currently available therapies.
Latest:
Changing the Perception and Conversation Around Disability: Sarah Todd HammerHammer, a patient advocate living with acute flaccid myelitis, discussed the language around neurologic disability, and how the conversations should shift going forward. [WATCH TIME: 4 minutes]
Latest:
Potential of Device-Assisted Therapy for Advanced-Stage Parkinson Disease: David Devos, MD, PhDThe neuropharmacologist at the University of Lille, in France, provided commentary on promising results from the phase 1/2 DIVE-I trial assessing the safety and efficacy of a device-assisted therapy in Parkinson disease. [WATCH TIME: 6 minutes]
Latest:
Insights on Addressing Disparities in Alzheimer Disease Research: Renã A. S. Robinson, PhDThe full professor of chemistry at Vanderbilt University talked about research surrounding racial and ethnic disparities in Alzheimer disease incidence. [WATCH TIME: 5 minutes]
Latest:
Parkinson Disease Subtyping: Are We There Yet?Heterogeneity suggests that identifying different types of Parkinson disease could improve patient management, the understanding of underlying disease mechanisms, and the development of target-specific therapies.
